ClinicalTrials.gov
public full text
Public Domain
Effectiveness of Cannabinoids on Appetite in Scleroderma
The cannabinoid has benefits in many aspects but the evidence of the effect of cannabinoids in humans with SSc is limited. We, therefore, would like to investigate the efficacy of cannabinoids on the appetite, sleep efficiency, quality of life, pain, and critical cytokine level in SSc compared with placebo in SSc patients and the adverse events associated with cannabinoids in those patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)#836528
- Behavioral Pharmacology of Cannabis and Nicotine#880662
- Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers#857772
- Search strategy of Does co-administration of cannabidiol influence the behavioral, subjective, or physiological effects of delta-9-tetrahydrocannabinol in humans?#204945
- N-acetylcysteine Effects on Tetrahydrocannabinol#825100
Record · ID 874688
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive